ENTERA BIO LTD. Capital Expenditures
ENTERA BIO LTD. (ENTX) reported Capital Expenditures of $3.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $3.00K, a 89.66% decline year-over-year.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $27.00K, a 800.00% increase year-over-year.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $43.00K.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for fiscal 2025 was $107.00K, a 3466.67% increase from fiscal 2024.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for fiscal 2024 was $3.00K, a 82.35% decline from fiscal 2023.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for fiscal 2023 was $17.00K, a 63.83% decline from fiscal 2022.
- ENTERA BIO LTD. payments to acquire property, plant, and equipment for fiscal 2022 was $47.00K, a 176.47% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.00K 10-Q · filed 2026-08-07 | $30.00K derived: sum of 3 quarters · filed 2026-08-07 | $73.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $27.00K derived: sum of 2 quarters · filed 2026-05-08 | $70.00K derived: sum of 3 quarters · filed 2026-05-08 | $99.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $70.00K derived: sum of 2 quarters · filed 2026-03-27 | $99.00K derived: sum of 3 quarters · filed 2026-08-07 | $107.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $72.00K derived: sum of 2 quarters · filed 2026-08-07 | $80.00K 10-Q · filed 2025-11-14 | $83.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $37.00K 10-Q · filed 2026-08-07 | $40.00K derived: sum of 3 quarters · filed 2026-08-07 | $40.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-08 | $11.00K derived: sum of 2 quarters · filed 2026-05-08 | $11.00K derived: sum of 3 quarters · filed 2026-05-08 | $11.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.00K derived: sum of 2 quarters · filed 2026-03-27 | $3.00K derived: sum of 3 quarters · filed 2026-03-27 | $3.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $5.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $5.00K derived: sum of 3 quarters · filed 2025-08-08 | $5.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $5.00K derived: sum of 2 quarters · filed 2025-05-09 | $5.00K derived: sum of 3 quarters · filed 2025-05-09 | $6.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $5.00K derived: sum of 2 quarters · filed 2025-03-28 | $6.00K derived: sum of 3 quarters · filed 2025-03-28 | $17.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.00K derived: sum of 2 quarters · filed 2024-11-08 | $12.00K 10-Q · filed 2024-11-08 | $15.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $12.00K 10-Q · filed 2024-08-09 | $15.00K derived: sum of 3 quarters · filed 2024-08-09 | $17.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $11.00K 10-Q · filed 2024-05-10 | $14.00K derived: sum of 2 quarters · filed 2024-05-10 | $16.00K derived: sum of 3 quarters · filed 2024-05-10 | $35.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $5.00K derived: sum of 2 quarters · filed 2024-03-08 | $24.00K derived: sum of 3 quarters · filed 2024-03-08 | $47.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $21.00K derived: sum of 2 quarters · filed 2023-11-14 | $44.00K 10-Q · filed 2023-11-14 | $54.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $42.00K 10-Q · filed 2023-08-11 | $52.00K derived: sum of 3 quarters · filed 2023-08-11 | $59.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $23.00K 10-Q · filed 2023-05-05 | $33.00K derived: sum of 2 quarters · filed 2023-05-05 | $40.00K derived: sum of 3 quarters · filed 2023-05-05 | $40.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $17.00K derived: sum of 2 quarters · filed 2023-03-31 | $17.00K derived: sum of 3 quarters · filed 2023-03-31 | $17.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $7.00K derived: sum of 2 quarters · filed 2022-11-10 | $7.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $53.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |